CLINICAL_TRIALS
trial_result
· 2021-12-08
Clinical Trial Update: Study of INCB053914 in Subjects With Advanced Malignancies [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of INCB053914 in subjects with advanced solid tumors has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-12-08